In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Essential considerations for a successful submission under EU CTR
A key feature of the EU CTR is the introduction of a single electronic portal, the Clinical Trial Information System (CTIS), which is mandatory for all EU CTR submissions. CTIS enables harmonised and simplified end-to-end electronic application procedures over the lifecycle of clinical trials across the EU/EEA.
Published by International Biopharmaceutical Industry Journal Volume 6 Issue 2
-
Comparing treatment performance through evidence synthesis
If there is a variety of treatment options in a specific disease area, decision makers require evidence of efficacy and safety of novel interventions in comparison to established treatments. One randomised controlled trial (RCT) is not sufficient to come to a final conclusion, especially since RCTs often present contradictory results.
Published by Journal for Clinical Studies Volume 15 Issue 2 (https://journalforclinicalstudies.com/).
-
Accessibility in rare disease paediatric clinical trials
In this International Pharmaceutical Industry article, ICON experts Kirsten Sherman Cervati and William C. Maier discuss strategies to make clinical trials more accessible for Paediatric patients and their families.
-
Clinical translation and linguistic validation at scale
Senior Vice President of Commercialisation & Outcomes, Brian Mallon, joins SlatorPod to shed light on the crucial role of language services within clinical research organisations.
-
ICON unveils latest version of its Digital Platform
This news article, published on Contract Pharma, reports on the latest release of the ICON Digital Platform, which supports the integration of ICON patient, site and sponsor services with the delivery of harmonized data and can be customised for any study design, from traditional to fully decentralised.
-
The top 25 healthcare technology leaders of New Jersey for 2023
Steve Cutler, CEO and Helen Yeardley, Senior Vice President, Global Clinical Operations feature in the The Healthcare Technology Report’s listing of the top 25 healthcare technology leaders of New Jersey for 2023.
-
Regulatory considerations in technology for decentralised clinical trials
This article in the Journal of mHealth explores the guidance regulators have provided for diversity and inclusion in clinical trials, privacy considerations and endpoint selection, and is authored by Jo Hulbert, Executive Director, Global Regulatory Clinical Services with contributions from Arwa Shurrab, Senior Director, Global Regulatory Affairs and Priti Prasad, Senior Manager, Global Regulatory Affairs.
Copyright 2023 The Journal of mHealth (Simedics Ltd)
-
Bioanalytical outsourcing soars as drugs grow more complex
Radboud van Trigt, Senior Director of Bioanalytical Science, contributes to this article in Contract Pharma that looks at trends in bioanalytic outsourcing against the backdrop of the increasingly complex nature of modern-day therapeutics.
-
Moving closer to dynamic drug development
Dr Ute Berger, President of Development and Commercialisation Solutions and Ted Broering, President of Early Clinical and Bioanalytical Solutions contribute to this feature in BioPharm International, which looks at how novel solutions and improvements aimed at benefitting the drug development process with the right framework are coming to the fore.
Murphy, J.Moving Closer to Dynamic Drug Development. BioPharm International 36 (6) 2023.
-
Endpoints News LGBTQ+ Biopharma Leaders '23
Jon Newton, Vice President, Corporate Development, Innovative Partnerships & Strategic Healthcare is featured in this report which profiles a group of scientists, executives, founders and academics who are leading the way for LGBTQ+ inclusion in the drug development industry.
© Endpoints News 2023
